Global Biologic Therapy Market Overview:
Global Biologic Therapy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Biologic Therapy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Biologic Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biologic Therapy Market:
The Biologic Therapy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Biologic Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biologic Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Biologic Therapy market has been segmented into:
Drugs
Instruments & Kits
Services
By Application, Biologic Therapy market has been segmented into:
Monoclonal Antibodies
Vaccines
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biologic Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biologic Therapy market.
Top Key Players Covered in Biologic Therapy market are:
Samsung Biologics (South Korea)
Amgen Inc (US)
Novo Nordisk A/S (Denmark)
Sanofi (France)
Johnson & Johnson Services
Inc (US)
Celltrion Healthcare Co.
Ltd (South Korea)
Bristol-Myers Squibb Company (US)
Eli Lilly and Company (US)
Hoffmann La-Roche Ltd (Switzerland)
Aeglea BioTherapuetics (US)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Biologic Therapy Market Type
4.1 Biologic Therapy Market Snapshot and Growth Engine
4.2 Biologic Therapy Market Overview
4.3 Drugs
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Drugs: Geographic Segmentation Analysis
4.4 Instruments & Kits
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Instruments & Kits: Geographic Segmentation Analysis
4.5 Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Services: Geographic Segmentation Analysis
Chapter 5: Biologic Therapy Market Application
5.1 Biologic Therapy Market Snapshot and Growth Engine
5.2 Biologic Therapy Market Overview
5.3 Monoclonal Antibodies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Monoclonal Antibodies: Geographic Segmentation Analysis
5.4 Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Vaccines: Geographic Segmentation Analysis
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Biologic Therapy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 SAMSUNG BIOLOGICS (SOUTH KOREA)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 AMGEN INC (US)
6.4 NOVO NORDISK A/S (DENMARK)
6.5 SANOFI (FRANCE)
6.6 JOHNSON & JOHNSON SERVICES
6.7 INC (US)
6.8 CELLTRION HEALTHCARE CO.
6.9 LTD (SOUTH KOREA)
6.10 BRISTOL-MYERS SQUIBB COMPANY (US)
6.11 ELI LILLY AND COMPANY (US)
6.12 HOFFMANN LA-ROCHE LTD (SWITZERLAND)
6.13 AEGLEA BIOTHERAPUETICS (US)
Chapter 7: Global Biologic Therapy Market By Region
7.1 Overview
7.2. North America Biologic Therapy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Drugs
7.2.2.2 Instruments & Kits
7.2.2.3 Services
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Monoclonal Antibodies
7.2.3.2 Vaccines
7.2.3.3 Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Biologic Therapy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Drugs
7.3.2.2 Instruments & Kits
7.3.2.3 Services
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Monoclonal Antibodies
7.3.3.2 Vaccines
7.3.3.3 Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Biologic Therapy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Drugs
7.4.2.2 Instruments & Kits
7.4.2.3 Services
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Monoclonal Antibodies
7.4.3.2 Vaccines
7.4.3.3 Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Biologic Therapy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Drugs
7.5.2.2 Instruments & Kits
7.5.2.3 Services
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Monoclonal Antibodies
7.5.3.2 Vaccines
7.5.3.3 Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Biologic Therapy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Drugs
7.6.2.2 Instruments & Kits
7.6.2.3 Services
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Monoclonal Antibodies
7.6.3.2 Vaccines
7.6.3.3 Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Biologic Therapy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Drugs
7.7.2.2 Instruments & Kits
7.7.2.3 Services
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Monoclonal Antibodies
7.7.3.2 Vaccines
7.7.3.3 Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Biologic Therapy Scope:
|
Report Data
|
Biologic Therapy Market
|
|
Biologic Therapy Market Size in 2025
|
USD XX million
|
|
Biologic Therapy CAGR 2025 - 2032
|
XX%
|
|
Biologic Therapy Base Year
|
2024
|
|
Biologic Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Samsung Biologics (South Korea), Amgen Inc (US), Novo Nordisk A/S (Denmark), Sanofi (France), Johnson & Johnson Services, Inc (US), Celltrion Healthcare Co., Ltd (South Korea), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), Hoffmann La-Roche Ltd (Switzerland), Aeglea BioTherapuetics (US).
|
|
Key Segments
|
By Type
Drugs
Instruments & Kits
Services
By Applications
Monoclonal Antibodies
Vaccines
Others
|
